ResMed Inc.

RMD Healthcare Medical Instruments & Supplies

ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025. In the quarter to June 2026, revenue grew 8.58%, EPS grew 2.32%, free cash flow fell 21.3% and total debt fell 39.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.

238.97 3.26 −1.35%
Market cap
$34.1B
P/E
22.8×
Fwd P/E
16.6×
Dividend yield
1.03%
F-score
6/9
Altman Z
10.00
Beneish M
−2.59
Dividend safety
96/100

ResMed Inc. (RMD) Book value per share

Alert me on Book value per share

ResMed Inc.'s book value per share at the end of fiscal 2026 was 45.3×, up 11.3% from 40.7× in fiscal 2025. Over the past ten years it has ranged from 11.3× (fiscal 2015) to 45.3× (fiscal 2026) — the current reading is the highest in ten years. ResMed Inc. ranks 6th of 55 Medical Instruments & Supplies companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2026 45.3× 11.25%
FY2025 40.7× 22.95%
FY2024 33.1× 17.57%
FY2023 28.1× 22.30%
FY2022 23.0× 15.86%
FY2021 19.9× 14.79%
FY2020 17.3× 19.48%
FY2019 14.5× 0.40%
FY2018 14.4× 4.00%
FY2017 13.9× 14.75%

Quarterly newest first

Period Book value per share Change
Jun 2026 45.3× 1.31%
Mar 2026 44.7× 3.06%
Dec 2025 43.3× 3.50%
Sep 2025 41.9× 2.95%
42 more quarters

Against its own ten years

Low 11.3× High 45.3×
Ten-year median 18.6×
Current reading's percentile 100

Book value per share against peers

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on RMD